Literature DB >> 9378993

Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model.

R P Taylor1, E N Martin, M L Reinagel, A Nardin, M Craig, Q Choice, R Schlimgen, S Greenbaum, N L Incardona, H D Ochs.   

Abstract

We used Anger camera imaging in a monkey model to investigate the organ localization of a prototype particulate pathogen, 131I-labeled bacteriophage phi X174, after it was bound to the primate erythrocyte complement receptor and then cleared from the circulation. This 131I-labeled phi X174 was infused into the circulation of an immunized monkey, and the nascently formed immune complexes showed rapid and quantitative binding to erythrocytes via the immune adherence reaction (complement-mediated binding). Alternatively, phi X174 was infused into the circulation of a naive animal, and then cross-linked bispecific mAb complexes (heteropolymers, anti-CR1 x anti-phi X174) were infused into the circulation. The infused heteropolymers also facilitated rapid and quantitative binding of phi X174 to erythrocytes. In both cases, after a short lag period, the erythrocyte-bound phi X174 was rapidly cleared from the circulation, and the vast majority of the radiolabel was cleared to the liver, with a small amount clearing to the spleen. Further liver imaging confirmed that within 24 h most of the bacteriophage previously cleared to the liver via the heteropolymer system was phagocytosed and destroyed. The findings in this model system provide additional evidence for the potential utility of heteropolymers to facilitate the safe and rapid clearance of blood-borne pathogens as a potential treatment for infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 2.  Bispecific antibodies for viral immunotherapy.

Authors:  Elisabeth K Nyakatura; Alexandra Y Soare; Jonathan R Lai
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

3.  Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.

Authors:  William D Brubaker; Andrés Crane; Jenny U Johansson; Kevin Yen; Kristina Garfinkel; Diego Mastroeni; Priya Asok; Bonnie Bradt; Marwan Sabbagh; Tanya L Wallace; Courtney Glavis-Bloom; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-05-02       Impact factor: 21.566

4.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.

Authors:  Andrés Crane; William D Brubaker; Jenny U Johansson; Abhishek Trigunaite; Justine Ceballos; Bonnie Bradt; Courtney Glavis-Bloom; Tanya L Wallace; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-07-26       Impact factor: 21.566

Review 5.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17

6.  PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.

Authors:  Jie Li; David T Glover; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

7.  Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes.

Authors:  Armindo Salvador; Michael A Savageau
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

8.  Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.

Authors:  Rashmi Sharma; Huiwu Zhao; Fetweh H Al-Saleem; Ahmed Syed Ubaid; Rama Devudu Puligedda; Andrew T Segan; Margaret A Lindorfer; Rodney Bermudez; Md Elias; Sharad P Adekar; Lance L Simpson; Ronald P Taylor; Scott K Dessain
Journal:  Mol Immunol       Date:  2013-11-01       Impact factor: 4.407

9.  Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.

Authors:  Jie Li; Alexander J Szalai; Susan K Hollingshead; Moon H Nahm; David E Briles
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

Review 10.  Bispecific antibodies and their applications.

Authors:  Gaowei Fan; Zujian Wang; Mingju Hao; Jinming Li
Journal:  J Hematol Oncol       Date:  2015-12-21       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.